ArticleDrug discovery today. Technologies2012
Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors.
Selwyn J Hurwitz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papertrialcites it